Role of Pyrazole Moiety in the Treatment of Alzheimer's Disease: A Comprehensive Review of Various Synthetic Routes and Probable Mechanisms of Action

被引:0
作者
Thakur, Aman [1 ]
Singh, Ranjit [1 ]
Mehta, Vineet [2 ]
Paliwal, Deepika [3 ]
机构
[1] Shobhit Univ, Adarsh Vijendra Inst Pharmaceut Sci, Saharanpur 247341, Uttar Pradesh, India
[2] Govt Coll Pharm, Dept Pharmacol, Shimla 171207, Himachal Prades, India
[3] Galgotias Univ, Sch Med & Allied Sci, Greater Noida 203201, Uttar Pradesh, India
来源
CHEMISTRYSELECT | 2025年 / 10卷 / 13期
关键词
Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Cholinesterase; MAO; Pyrazole; Synthesis; LEUCINE-ZIPPER KINASE; AMYLOID-BETA-PROTEIN; OXIDASE-B INHIBITORS; MONOAMINE-OXIDASE; BIOLOGICAL EVALUATION; CHOLINERGIC HYPOTHESIS; SENILE PLAQUES; SIGNAL-TRANSDUCTION; IN-VITRO; NEURONAL DEGENERATION;
D O I
10.1002/slct.202500130
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Alzheimer's disease (AD) has emerged as a healthcare burden in recent times in both, developing and developed nations. This could be attributed to the involvement of complex pathology and limited treatment options available for the management of AD. Currently, available therapeutic strategies fail to cure or reverse AD and associated complications and are primarily focused on providing symptomatic relief. Therefore, the need to identify a novel therapeutic strategy has become evident, for which pyrazole-based moieties are being considered as promising options. Pyrazole being one of the most widely exploited heterocyclic moieties against various disorders holds great potential for the development of anti-Alzheimer drugs. The current review focuses on recent advances in the synthetic approaches employed for the development of various pyrazole analogs for the treatment of AD and their mechanisms of action. The structural activity relationship of these derivatives on certain targets of AD has also been discussed which may help to draw new ideas for the development of potent anti-AD pyrazole derivatives.
引用
收藏
页数:25
相关论文
共 215 条
[21]   New Coumarin-Pyrazole hybrids: Synthesis, Docking studies and Biological evaluation as potential cholinesterase inhibitors [J].
Benazzouz-Touami, Amina ;
Chouh, Amina ;
Halit, Sabrina ;
Terrachet-Bouaziz, Souhila ;
Makhloufi-Chebli, Malika ;
Ighil-Ahriz, Karima ;
Silva, Artur M. S. .
JOURNAL OF MOLECULAR STRUCTURE, 2022, 1249
[22]   A Perspective on Multi-target Drugs for Alzheimer's Disease [J].
Benek, Ondrej ;
Korabecny, Jan ;
Soukup, Ondrej .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (07) :434-445
[23]   Rivastigmine for Alzheimer's disease [J].
Birks, Jacqueline S. ;
Chong, Lee Yee ;
Evans, John Grimley .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09)
[24]  
Borsello T, 2007, CURR PHARM DESIGN, V13, P1875
[25]   Anticancer effect of three pyrazole derivatives [J].
Bouabdallah, Ibrahim ;
M'Barek, Lahcen Ait ;
Zyad, Abdelmajid ;
Ramdani, Abdelkrim ;
Zidane, Ismail ;
Melhaoui, Ahmed .
NATURAL PRODUCT RESEARCH, 2006, 20 (11) :1024-1030
[26]   Recent Developments in the Chemistry of Pyrazoles [J].
Brown, Andrew W. .
ADVANCES IN HETEROCYCLIC CHEMISTRY, VOL 126, 2018, 126 :55-107
[27]   JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function [J].
Busquets, Oriol ;
Espinosa-Jimenez, Triana ;
Ettcheto, Miren ;
Olloquequi, Jordi ;
Bullo, Monica ;
Carro, Eva ;
Cantero, Jose Luis ;
Casadesus, Gemma ;
Folch, Jaume ;
Verdaguer, Ester ;
Auladell, Carme ;
Camins, Antoni .
MOLECULAR MEDICINE, 2022, 28 (01)
[28]   WHO's global action plan on the public health response to dementia: some challenges and opportunities [J].
Cahill, Suzanne .
AGING & MENTAL HEALTH, 2020, 24 (02) :197-199
[29]  
Carr D. B., 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)00262-3
[30]   Alzheimer Disease [J].
Castellani, Rudy J. ;
Rolston, Raj K. ;
Smith, Mark A. .
DM DISEASE-A-MONTH, 2010, 56 (09) :484-546